Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

W. Feldman · SciRah

Researcher profile · Semantic Scholar

W. Feldman

Share profile

W. Feldman — researcher profile on SciRah

h-index: 16
Works: 85
Citations: 1,561

Most-cited papers

Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.
Shirley V. Wang, S. Schneeweiss, J. Franklin, R. Desai +23 more
2023Journal of the American Medical Association (JAMA)364 citations Open access
Semantic Scholar
Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991.
Michael B. H. Smith, W. Feldman
1993Journal of the American Medical Association (JAMA)228 citations
Semantic Scholar
High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions.
Edward R. Scheffer Cliff, Amar H. Kelkar, D. Russler-Germain, Frazer A. Tessema +3 more
2023American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting122 citations Open access
Semantic Scholar
Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review.
W. Feldman, A. Clark, M. Safaee, C. Ames +1 more
2013Journal of Neurosurgery : Spine84 citations
Semantic Scholar
Patents and regulatory exclusivities on GLP-1 receptor agonists
Rasha Alhiary, A. Kesselheim, Sarah M. E. Gabriele, R. Beall +2 more
2023Journal of the American Medical Association (JAMA)60 citations Open access
Semantic Scholar
Estimating Rebates and Other Discounts Received by Medicare Part D.
W. Feldman, Benjamin N. Rome, V. Raimond, J. Gagne +1 more
2021JAMA Health Forum42 citations Open access
Semantic Scholar
Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022
Benjamin N. Rome, Sarosh Nagar, Alexander C. Egilman, Junyi Wang +2 more
2023JAMA Health Forum41 citations Open access
Semantic Scholar
Public Approval of Exception From Informed Consent in Emergency Clinical Trials
W. Feldman, S. Hey, J. Franklin, A. Kesselheim
2019JAMA Network Open38 citations Open access
Semantic Scholar
A Systematic Review Of The Food And Drug Administration's 'Exception From Informed Consent' Pathway.
W. Feldman, S. Hey, A. Kesselheim
2018Health Affairs38 citations
Semantic Scholar
Patents and regulatory exclusivities on inhalers for asthma and COPD, 1986-2020
W. Feldman, D. Bloomfield, R. Beall, A. Kesselheim
2022Health Affairs33 citations Open access
Semantic Scholar
Biosimilar competition: Early learning.
R. Frank, Mahnum Shahzad, A. Kesselheim, W. Feldman
2021Health Economics33 citations Open access
Semantic Scholar
Outcomes of the 340B Drug Pricing Program
Ryan P Knox, Junyi Wang, W. Feldman, Aaron S. Kesselheim +1 more
2023JAMA Health Forum31 citations Open access
Semantic Scholar
Trends in recruitment rates for acute stroke trials, 1990–2014
W. Feldman, Anthony S. Kim, W. Chiong
2017Stroke30 citations Open access
Semantic Scholar
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
Benjamin N. Rome, W. Feldman, R. Desai, A. Kesselheim
2021JAMA Network Open26 citations Open access
Semantic Scholar
Assessment of Prices for Cardiovascular Tests and Procedures at Top-Ranked US Hospitals.
A. Oseran, Shylie Ati, W. Feldman, S. Gondi +2 more
2022JAMA Internal Medicine23 citations Open access
Semantic Scholar
Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers.
W. Feldman, J. Avorn, A. Kesselheim, J. Gagne
2023JAMA Internal Medicine18 citations Open access
Semantic Scholar
Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019
Anders Olsen, R. Beall, Ryan P Knox, S. Tu +2 more
2023PLoS Medicine16 citations Open access
Semantic Scholar
Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
V. Raimond, W. Feldman, Benjamin N. Rome, A. Kesselheim
2021Milbank Quarterly16 citations Open access
Semantic Scholar
Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals.
W. Feldman, Benjamin N. Rome, B. L. Brown, A. Kesselheim
2021JAMA Internal Medicine16 citations Open access
Semantic Scholar
Association Between USMLE Step 1 Scores and In-Training Examination Performance: A Meta-Analysis
N. Panda, D. Bahdila, Abeer Abdullah, Auyon J. Ghosh +2 more
2021Academic medicine : journal of the Association of American Medical Colleges14 citations Open access
Semantic Scholar
A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs
A. Sarpatwari, Mayookha Mitra-Majumdar, K. Bykov, J. Avorn +12 more
2021Drug Safety14 citations
Semantic Scholar
Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa.
A. Raymakers, Aaron S. Kesselheim, A. Mostaghimi, W. Feldman
2024JAMA dermatology13 citations
Semantic Scholar
Changes in the Number of Continuation Patents on Drugs Approved by the FDA.
S. S. Tu, A. Kesselheim, Kathrine Wetherbee, W. Feldman
2023Journal of the American Medical Association (JAMA)13 citations Open access
Semantic Scholar
Medicare Spending on Drugs With Accelerated Approval, 2015-2019
Benjamin N. Rome, W. Feldman, A. Kesselheim
2021JAMA Health Forum13 citations Open access
Semantic Scholar
Patenting strategies on inhaler delivery devices.
Brandon J Demkowicz, S. S. Tu, A. Kesselheim, Michael A. Carrier +1 more
2023Chest12 citations Open access
Semantic Scholar
Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States
Julia Jezmir, Maheetha Bharadwaj, Alexander M. Chaitoff, Bradford Diephuis +12 more
2021Cell Reports Medicine12 citations Open access
Semantic Scholar
Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary.
W. Feldman, Benjamin N. Rome, L. Lehmann, A. Kesselheim
2020JAMA Internal Medicine12 citations Open access
Semantic Scholar
A Comparative Analysis of International Drug Price Negotiation Frameworks: An Interview Study of Key Stakeholders.
Iselin Dahlen Syversen, Kevin A. Schulman, Aaron S. Kesselheim, W. Feldman
2024Milbank Quarterly11 citations
Semantic Scholar
Trust in the Food and Drug Administration: A National Survey Study
W. Feldman, Leah Z. Rand, Daniel P Carpenter, Massimiliano Russo +5 more
2024Clinical pharmacology and therapy11 citations Open access
Semantic Scholar
Patent Challenges And Litigation On Inhalers For Asthma And COPD.
Sanjay Reddy, R. Beall, S. S. Tu, A. Kesselheim +1 more
2023Health Affairs11 citations
Semantic Scholar
Addressing Challenges Associated with Operationalizing a Crisis Standards of Care Protocol for the Covid-19 Pandemic
Aimee Milliken, M. Jurchak, N. Sadovnikoff, W. Feldman +4 more
2020Nejm Catalyst Innovations in Care Delivery11 citations
Semantic Scholar
Cost of Exempting Sole Orphan Drugs From Medicare Negotiation.
Matthew Vogel, Olivia Zhao, W. Feldman, Amitabh Chandra +2 more
2023JAMA Internal Medicine10 citations Open access
Semantic Scholar
Switching to Over-the-Counter Availability of Rescue Inhalers for Asthma.
W. Feldman, J. Avorn, A. Kesselheim
2022Journal of the American Medical Association (JAMA)9 citations
Semantic Scholar
The Future of Drug-Pricing Transparency.
W. Feldman, Benjamin N. Rome, J. Avorn, A. Kesselheim
2021New England Journal of Medicine9 citations
Semantic Scholar
Trends in Medicare Part D Inhaler Spending, 2012-2018.
W. Feldman, J. Gagne, A. Kesselheim
2020Annals of the American Thoracic Society9 citations Open access
Semantic Scholar
Ensuring Ethical Postprogression Therapy for Patients in Randomized Trial Control Arms.
Edward R. Scheffer Cliff, A. Kesselheim, W. Feldman
2023Journal of Clinical Oncology8 citations
Semantic Scholar
Coverage of New Drugs in Medicare Part D
H. Naci, I. Kyriopoulos, W. Feldman, T. Hwang +2 more
2022Milbank Quarterly8 citations Open access
Semantic Scholar
Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary.
W. Feldman, J. Avorn, A. Kesselheim
2019JAMA Internal Medicine8 citations Open access
Semantic Scholar
Removing the FDA’s Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan
W. Feldman, M. Mahesri, A. Sarpatwari, K. Huybrechts +13 more
2024JAMA Network Open7 citations Open access
Semantic Scholar
The Rise and Fall of the Insulin Pricing Bubble.
W. Feldman, Benjamin N. Rome
2023JAMA Network Open7 citations Open access
Semantic Scholar
Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines.
L. Rand, Daniel P Carpenter, Aaron S. Kesselheim, Anushka Bhaskar +2 more
2023The Hastings center report7 citations
Semantic Scholar
Product Hopping in the Drug Industry - Lessons from Albuterol.
O. Wouters, W. Feldman, S. S. Tu
2022New England Journal of Medicine7 citations Open access
Semantic Scholar
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease
W. Feldman, Aaron S. Kesselheim, J. Avorn, Massimiliano Russo +1 more
2023Annals of Internal Medicine6 citations
Semantic Scholar
Brand-name market exclusivity for nebulizer therapy to treat asthma and COPD
W. Feldman, D. Bloomfield, R. Beall, A. Kesselheim
2022Nature Biotechnology6 citations Open access
Semantic Scholar
Persistent perceptual disturbances after lithium toxicity: a case report and discussion.
W. Feldman, Aaron D. Besterman, J. J. Yu, Jeffrey J. DeVido +1 more
2015Psychosomatics6 citations Open access
Semantic Scholar
Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the Evidence
S. Hey, W. Feldman, E. Jung, E. D'Andrea +1 more
2019Journal of Law, Medicine & Ethics5 citations
Semantic Scholar
Global Access to Chimeric Antigen Receptor (CAR) T-Cell Therapies: Health Technology Assessment (HTA) of CAR T in G7 Countries and Australia
Alex Y. Ge, W. Feldman, Martin F. Kaiser, K. Rejeski +4 more
2024Blood4 citations
Semantic Scholar
Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020
Edward R. Scheffer Cliff, A. Kesselheim, Benjamin N. Rome, W. Feldman
2023JAMA Network Open4 citations Open access
Semantic Scholar
Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseases
Victor L. Van de Wiele, Maximilian Hammer, R. Parikh, W. Feldman +2 more
2022Journal of Law and the Biosciences4 citations Open access
Semantic Scholar
Empirical Assessment of COVID-19 Crisis Standards of Care Guidelines
Julia Jezmir, Maheetha Bharadwaj, S. Kishore, Marisa L. Winkler +3 more
2020medRxiv4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Kesselheim×29
Invite
A. Kesselheim — researcher profile on SciRah
Benjamin N. Rome×11
Invite
Benjamin N. Rome — researcher profile on SciRah
Aaron S. Kesselheim×6
Invite
Aaron S. Kesselheim — researcher profile on SciRah
S. S. Tu×5
Invite
S. S. Tu — researcher profile on SciRah

×5

Invite

J. Avorn — researcher profile on SciRah

Edward R. Scheffer Cliff×4

Invite

Edward R. Scheffer Cliff — researcher profile on SciRah

Invite

R. Beall — researcher profile on SciRah

Invite

J. Gagne — researcher profile on SciRah

A. Sarpatwari×4

Invite

A. Sarpatwari — researcher profile on SciRah

Invite

S. Hey — researcher profile on SciRah

Aaron S. Kesselheim×3

Invite

Aaron S. Kesselheim — researcher profile on SciRah

Shirley V. Wang×2

Invite

Shirley V. Wang — researcher profile on SciRah